Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Important Notes Important Notes These practical guidelines are included to support consistency, dosing accuracy, and proper handling throughout an educational, research-style peptide protocol
50RolandoN, HarveyF, BrahmJ,
Tirzepatide (Dual GIP/GLP-1 Agonist) Tirzepatide is a dual GIP/GLP-1 receptor agonist FDA-approved as Mounjaro (type 2 diabetes, 2022) and Zepbound (obesity, 2023)
It does not contain semaglutide, tirzepatide, or any pharmaceutical GLP-1 receptor agonist
US$ 22.88
US$ 29.45
US$ 27.37
US$ 23.25
US$ 27.50
US$ 25.97
US$ 25.15
US$ 20.68
